4.4 Review

An Overview of Pituitary Neuroendocrine Tumors (PitNET) and Algorithmic Approach to Diagnosis

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Overview of the 2022 WHO Classification of Pituitary Tumors

Sylvia L. Asa et al.

Summary: This review summarizes the changes in the 5th Edition of the WHO Classification of Endocrine and Neuroendocrine Tumors related to the pituitary gland, including the classification of pituitary lobe tumors and the detailed subtyping based on tumor cell lineage, cell type, and characteristics.

ENDOCRINE PATHOLOGY (2022)

Article Pathology

Cytokeratin profiles in pituitary neuroendocrine tumors

Sylvia L. Asa et al.

Summary: The presence and patterns of keratins play a critical role in the classification of pituitary neuroendocrine tumors. CAM 5.2 and CK18 are the most valuable markers, with almost identical staining patterns observed.

HUMAN PATHOLOGY (2021)

Review Oncology

Pituitary adenoma or pituitary neuroendocrine tumor: a narrative review of controversy and perspective

Xiaohai Liu et al.

Summary: Pituitary adenomas are common intracranial neoplasms, most of which can be cured or controlled by conventional therapies, but some have invasive and malignant transformations. The International Pituitary Pathology Club proposed a new term "pituitary neuroendocrine tumor", which may cause patient confusion and anxiety according to some studies.

TRANSLATIONAL CANCER RESEARCH (2021)

Review Pathology

Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification

Sylvia L. Asa et al.

Summary: The classification of adenohypophysial neoplasms as pituitary neuroendocrine tumors (PitNETs) reflects their characteristics as epithelial neuroendocrine neoplasms with a spectrum of clinical behaviors. Tumor growth and hormone hypersecretion can cause significant morbidity and mortality in patients. The intense study of PitNETs has provided important information about the importance of cellular differentiation in tumor prognosis.

MODERN PATHOLOGY (2021)

Review Medicine, General & Internal

An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism

Sylvia L. Asa et al.

Summary: Excess growth hormone causes gigantism and acromegaly, which are characterized by accelerated growth and overgrowth of soft tissue and bone. Pituitary neuroendocrine tumors (PitNETs) that produce GH are primarily derived from PIT1-lineage cells, with various pathologic features. These tumors may vary in hormone production and lineage differentiation, resulting in GH excess.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Endocrinology & Metabolism

Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations

Olivera Casar-Borota et al.

Summary: ATRX mutations are common in a subset of aggressive pituitary tumors, particularly in corticotroph tumors. Performing ATRX immunohistochemistry can help identify patients at risk of developing aggressive and potentially metastatic pituitary tumors.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Review Medicine, General & Internal

The Clinicopathological Spectrum of Acromegaly

Amit Akirov et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Article Pathology

Epidemiology and biomarker profile of pituitary adenohypophysial tumors

Ozgur Mete et al.

MODERN PATHOLOGY (2018)

Review Endocrinology & Metabolism

Overview of the 2017 WHO Classification of Pituitary Tumors

Ozgur Mete et al.

ENDOCRINE PATHOLOGY (2017)

Article Clinical Neurology

Functional Gonadotroph Adenomas: Case Series and Report of Literature

David J. Cote et al.

NEUROSURGERY (2016)

Review Endocrinology & Metabolism

Cushing's syndrome: update on signs, symptoms and biochemical screening

Lynnette K. Nieman

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)

Article Medical Laboratory Technology

Therapeutic implications of accurate classification of pituitary adenomas

Ozgur Mete et al.

SEMINARS IN DIAGNOSTIC PATHOLOGY (2013)

Article Clinical Neurology

Clinical features of silent corticotroph adenomas

Hussein Alahmadi et al.

ACTA NEUROCHIRURGICA (2012)

Review Clinical Neurology

Clinicopathological Correlations in Pituitary Adenomas

Ozgur Mete et al.

BRAIN PATHOLOGY (2012)

Article Oncology

PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis

Dario Palmieri et al.

ENDOCRINE-RELATED CANCER (2012)

Article Multidisciplinary Sciences

Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly

Andrea Giustina et al.

PLOS ONE (2012)

Article Endocrinology & Metabolism

Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience

D. Erickson et al.

CLINICAL ENDOCRINOLOGY (2009)

Article Cell Biology

Somatostatin agonists for treatment of acromegaly

Anat Ben-Shlomo et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)

Article Endocrinology & Metabolism

P53 gene mutations in pituitary carcinomas

Yoshinori Tanizaki et al.

ENDOCRINE PATHOLOGY (2007)

Review Medicine, General & Internal

Medical progress: Acromegaly

Shlomo Melmed

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Multidisciplinary Sciences

Pituitary adenoma predisposition caused by germline mutations in the AIP gene

Outi Vierimaa et al.

SCIENCE (2006)

Article Clinical Neurology

Gender-related differences in prolactin secretion in pituitary prolactinomas

H Nishioka et al.

NEURORADIOLOGY (2002)

Review Multidisciplinary Sciences

Development - Pituitary development: Regulatory codes in mammalian organogenesis

KM Scully et al.

SCIENCE (2002)

Article Radiology, Nuclear Medicine & Medical Imaging

Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

JC Reubi et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)